- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01139879
P400 for Stage II-IV Pressure Ulcers in Home and Extended Care (P400)
November 16, 2015 updated by: Hill-Rom
Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress
To assess the efficacy of a pressure ulcer treatment mattress, the P400 mattress, in the treatment of multiple Stage II or one or more large Stage III or IV pressure ulcers in the home care and extended care (nursing home) environment.
Study Overview
Detailed Description
Subjects will be recruited from those presenting to the wound clinic and meet the inclusion criteria.
A total of 30 evaluable subjects will be recruited for this study from up to 2 wound care clinics /home health agencies (15 in Home Care and 15 in Extended Care).
Subjects will be followed by weekly wound assessments for a period of 12 weeks or until their wounds heal.
The outcome measurement is the rate of healing over the 12 week period.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79410
- Southwest Regional Wound Care Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject has multiple Stage II pressure ulcers or at least one Stage III or IV pressure ulcer(s) (as per National Pressure Ulcer Advisory Panel Staging guidelines) located either on the trunk or pelvis (which would include trochanter and ischial ulcers ) having a clean wound bed of less than or equal to 25% necrotic tissue at the base of the pressure ulcer.
- Subjects may have heel ulcers, however these ulcers may not be considered a target study ulcer.
- Subject, or legally authorized representative is able to provide informed consent
- Subject weighs between 70 and 350 pounds
- Subject's nutritional status is thought to be adequate to support wound healing
- Subject qualifies for a Group 2 support surface (Target study ulcer must be at least 8 cm^2 in area to qualify)
Exclusion Criteria:
- Subject's target ulcer is unstageable due to eschar or necrosis or a suspected Deep Tissue Injury may be located at the base of the wound.
- Subject has unresolved systemic infection, or pressure ulcer infection, or a history of osteomyelitis, or greater than 25% eschar or necrotic tissue present in the wound bed.
- Patient has already been enrolled in this study
- Patient has a recent history of non-compliance with pressure ulcer offloading, repositioning, or other areas of the treatment care plan, which would jeopardize wound healing if continued.
- Care plan goals are palliative
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: P400 support surface
All patients will receive the P400 mattress
|
The P400 mattress will be placed for a period of 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in Ulcer Surface Area at Week 12
Time Frame: 12 Weeks
|
The primary outcome measure for this study is to be healing rate by area, based on the identified target study ulcer.
|
12 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of New Ulcers
Time Frame: 12 Weeks
|
incidence of new ulcers while on the study surface
|
12 Weeks
|
Healing Rate Per Week
Time Frame: 12 weeks
|
The mean change in area per week for all ulcers
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Randall Wolcott, MD, Randall Wolcott and Assoiciates
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
June 7, 2010
First Submitted That Met QC Criteria
June 8, 2010
First Posted (Estimate)
June 9, 2010
Study Record Updates
Last Update Posted (Estimate)
December 17, 2015
Last Update Submitted That Met QC Criteria
November 16, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-0092
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcers
-
KLOX Technologies Inc.CompletedPressure Ulcers Stage II | Pressure Ulcers Stage IIICanada
-
EmoledRecruitingPressure Ulcer | Pressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure SoreItaly
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Signorini Medicale S.r.l.Opera CRO, a TIGERMED Group CompanyNot yet recruitingBurn Wound | Pressure Ulcers Stage II | Pressure Ulcers Stage IIIRomania
-
Charite University, Berlin, GermanyCompleted
-
Central Arkansas Veterans Healthcare SystemAbbottTerminatedPressure UlcersUnited States
-
Leaf Healthcare, Inc.Centauri Medical, Inc.Completed
-
Hill-RomCompletedPressure UlcersUnited States
-
Bruin Biometrics, LLCCompleted
Clinical Trials on P400 mattress
-
Istanbul University - Cerrahpasa (IUC)Yataş Yatak ve Yorgan San. Tic. A.Ş.CompletedSleep | Idiopathic ScoliosisTurkey
-
Stanford UniversityAIRWEAVE PTE. LTD.CompletedSleep DisordersUnited States
-
Beth Israel Medical CenterCompleted
-
Centre Hospitalier Universitaire de NīmesInvacare Poirier S.A.S.Completed
-
University of California, IrvineCompletedBack Pain | InsomniaUnited States
-
Hill-RomCompletedPressure UlcersUnited States
-
Jagiellonian UniversityCompletedAcute Kidney Injury | Bariatric Surgery Candidate | RhabdomyolysisPoland
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Sunnaas Rehabilitation HospitalCompletedPain | Sleep | Satisfaction, Patient | Noise Exposure | Pressure Injury | Strains | Satisfaction, PersonalNorway
-
Wake Forest University Health SciencesCompletedHot Flashes | MenopauseUnited States